Back to Treatments

Treatment

Pazopanib

1
Conditions
100
Trials
1,500
Participants
40%
Average Safety

Condition Evidence

Kidney cancer

100 trials · 1,500 participants

60% effectiveness · 40% safety
Pazopanib | DFDA